No abstract available
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / pharmacology*
-
Apoptosis
-
CSK Tyrosine-Protein Kinase
-
Cell Line, Tumor
-
Cyclin-Dependent Kinases / antagonists & inhibitors*
-
Cyclin-Dependent Kinases / metabolism
-
Cyclins / antagonists & inhibitors
-
Cyclins / metabolism
-
Drug Screening Assays, Antitumor
-
Humans
-
Indoles / chemistry
-
Indoles / pharmacology*
-
Inhibitor of Apoptosis Proteins
-
Microtubule-Associated Proteins / antagonists & inhibitors
-
Microtubule-Associated Proteins / metabolism
-
Monosaccharides / pharmacology*
-
Myeloid Cell Leukemia Sequence 1 Protein
-
Neoplasm Proteins / antagonists & inhibitors
-
Neoplasm Proteins / metabolism
-
Oximes
-
Phosphorylation
-
Protein Kinase Inhibitors / chemistry
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Protein-Tyrosine Kinases / metabolism
-
Proto-Oncogene Proteins / antagonists & inhibitors
-
Proto-Oncogene Proteins / metabolism
-
Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors
-
Proto-Oncogene Proteins c-bcl-2 / metabolism
-
Retinoblastoma Protein / metabolism
-
STAT3 Transcription Factor / antagonists & inhibitors
-
STAT3 Transcription Factor / metabolism
-
Survivin
-
src-Family Kinases
Substances
-
Antineoplastic Agents
-
BIRC5 protein, human
-
Cyclins
-
E671 bisindole
-
E729 bisindole
-
Indirubin E804
-
Indoles
-
Inhibitor of Apoptosis Proteins
-
Microtubule-Associated Proteins
-
Monosaccharides
-
Myeloid Cell Leukemia Sequence 1 Protein
-
Neoplasm Proteins
-
Oximes
-
Protein Kinase Inhibitors
-
Proto-Oncogene Proteins
-
Proto-Oncogene Proteins c-bcl-2
-
Retinoblastoma Protein
-
STAT3 Transcription Factor
-
STAT3 protein, human
-
Survivin
-
Protein-Tyrosine Kinases
-
CSK Tyrosine-Protein Kinase
-
src-Family Kinases
-
CSK protein, human
-
Cyclin-Dependent Kinases
-
indirubin